Vanda Pharmaceuticals Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$7.12

-1.45 (-16.92%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 80%

Hold 2 20%

Sell 0 0%

Price Target

Analyst Price Target +117.0% upside

Low Target $11.33

Average Target $15.45

High Target $18.37

Current Price $7.12

Current
$7.12

Target
$15.45

$11.33 $15.45 avg $18.37

Scenario Analysis

Bear Case

$11.33

59.1%

Low target

Base Case

$15.45

+117.0%

Avg target

Bull Case

$18.37

+158.0%

High target

Risk/Reward

2.7x

Favorable

Price in Context

52-Week High

$9.60

-25.8% from high

52-Week Low

$3.81

+86.9% from low

Target vs 52W High

$15.45

+60.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%